Apertura Gene Therapy

United Kingdom
Newyork, Argyll and Bute, United Kingdom, 10010

Company profile

Apertura Gene Therapy company profile

Apertura Gene Therapy offers treatment options for debilitating diseases with few options. It is in a unique position to develop genetic medicines by simultaneously engineering AAV capsids, regulatory elements, and payloads to overcome current gene therapy limitations. They are dedicated to the advancement of gene therapy and believe that by collaborating with corporate and academic partners, patients, and disease.

Business identity

Phone number
1.555.918.8251
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2021-01-01, Year

Headquarters

Postal code
10010
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$67M
Last funding
Series A / $67M / 2022-04-26
Last equity funding
Series A / $67M
Investors
1
Lead investors
1
Articles
14

Founders and investors

Lead investors

Deerfield

Investors

Deerfield